Pharma & Biotech

Fujirebio and Sysmex Collaborate to Advance Immunoassay Technology and Global Expansion

(IN BRIEF) Fujirebio Holdings and Sysmex Corporation have entered into a Basic Agreement on Business Collaboration in the field of…

2 years ago

Eni and Dompé farmaceutici Partner for Joint Research on Global Health Issues

(IN BRIEF) Eni CEO Claudio Descalzi and Dompé farmaceutici Executive Chairman Sergio Dompé have signed a Letter of Intent to…

2 years ago

GSK Forms Exclusive Partnership with Zhifei to Promote Shingrix Vaccine in China

(IN BRIEF) GSK plc has announced an exclusive agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to co-promote GSK's shingles…

2 years ago

Merck Partners with UN on Vital Training Course for Family Carers During European Carers Day

(IN BRIEF) Merck, a prominent science and technology company, has entered into a collaboration with the United Nations’ Global Initiative…

2 years ago

Roche’s Evrysdi Shows Promise in Pre-Symptomatic SMA Babies, Potentially Changing the Course of the Disease

(IN BRIEF) Roche has reported positive outcomes from the RAINBOWFISH study, an investigation into the efficacy and safety of Evrysdi®…

2 years ago

Sanofi and Teva Collaborate on Inflammatory Bowel Disease Treatment, TEV’574, in $1.5 Billion Deal

(IN BRIEF) Sanofi and Teva Pharmaceuticals have announced a collaboration to co-develop and co-commercialize TEV’574, a promising asset currently in…

2 years ago

Sandoz Group Lists Shares on SIX Swiss Exchange with CHF 10.3 Billion Market Capitalization

(IN BRIEF) Sandoz Group AG, a Novartis spin-off, officially listed its shares at the SIX Swiss Exchange. With an opening…

2 years ago

Sanofi Collaborates with Janssen on Vaccine for Extraintestinal Pathogenic E. coli

(IN BRIEF) Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and…

2 years ago

World Health Organization Recommends University of Oxford’s Malaria Vaccine for Children

(IN BRIEF) The University of Oxford's R21/Matrix-M™ malaria vaccine, developed in collaboration with the Serum Institute of India and leveraging…

2 years ago

EIB Backs Polish company SDS Optic Inc. with €10 Million Investment in Cutting-Edge Cancer Detection Tech

(IN BRIEF) The European Investment Bank (EIB) has signed a €10 million loan agreement with Polish company SDS Optic Inc.…

2 years ago